SecBot SecBot
144 ·Filed Apr 23, 2026

ECOR

electroCore, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001949846-26-000220
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for actual sale execution in upcoming Form 4 filings; given the small size and former executive status, this is a routine disposal and unlikely to impact the stock materially. However, continued insider selling could signal weakening confidence if volume increases.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ECOR ▼ -1.78% at T+60d
NEUTRAL call -1.78% · α vs SPY -6.80% · entry $6.18 → $6.07
Entry = T+0 close
Apr 23, 2026
via day close
T+1d
-0.08%
call -0.08% · α -0.87%
$6.18
settled 6mo ago
T+5d
-0.49%
call -0.49% · α -1.96%
$6.15
settled 6mo ago
T+20d
-0.81%
call -0.81% · α -5.44%
$6.13
settled 5mo ago
T+60d
-1.78%
call -1.78% · α -6.80%
$6.07
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Daniel S. Goldberger, former CEO of electroCore, Inc., filed a Form 144 to sell up to 10,000 shares of common stock, valued at approximately $61,300 based on the current market price. The shares are held in the Daniel S. Goldberger Revocable Trust and were acquired as compensation for his prior role as CEO.

Key Facts

  • Reporting person: Daniel S. Goldberger, former CEO of electroCore, Inc.
  • Number of shares proposed for sale: 10,000
  • Approximate value of shares: $61,300 (based on $6.13/share)
  • Shares held in: Daniel S. Goldberger Revocable Trust
  • Shares acquired on: August 4, 2024, as compensation for former CEO role
  • Filing date: April 23, 2026

Financial Impact

$61,300 sale value (0.12% of market cap)

insider ownershippotential share dilutionmarket sentiment

Risk Factors

  • Perception of insider lack of confidence, though mitigated by former CEO status
  • Potential short-term downward pressure if sale is executed near market close

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001949846-26-000220
Document: 0001949846-26-000220-index.html0001949846-26-000220
Document: 0001949846-26-000220.txt0001949846-26-000220
9 reports for ECOR
Performance horizon
Filters
Rows
Reports for ECOR — sortable, filterable
TypeNow
Sep 9, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$8.99 $9.72▲ +8.12%▲ +6.18%$7.05 (−21.58%)
May 27, 2026
21w ago
144
NEUTRAL ★ 2/10
$9.24 $7.19▼ −22.19%▼ −20.28%$7.05 (−23.70%)
May 14, 2026
23w ago
144
NEUTRAL ★ 2/10
$6.43 $10.25▲ +59.41%▲ +60.27%$7.05 (+9.64%)
May 5, 2026
24w ago
144
NEUTRAL ★ 4/10
$6.99 $9.45▲ +35.19%▲ +30.24%$7.05 (+0.86%)
Apr 29, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$6.15 $9.24▲ +50.24%▲ +44.78%$7.05 (+14.63%)
Apr 23, 2026
26w ago
144
NEUTRAL ★ 3/10
$6.18 $6.13▼ −0.81%▼ −5.44%$7.05 (+14.08%)
Apr 1, 2026
29w ago
Press Release
MIXED ★ 5/10
$6.60 $6.15▼ −6.82%▼ −16.54%$7.05 (+6.82%)
Mar 19, 2026
31w ago
Press Release
MIXED ★ 6/10
$6.25 $6.31▲ +0.96%▼ −8.36%$7.05 (+12.80%)
Mar 10, 2026
32w ago
Press Release
NEUTRAL ★ 3/10
$6.50 $6.21▼ −4.46%▼ −4.31%$7.05 (+8.46%)
Showing 9 of 9

US Market Status

Market Closed — Opens Wed (12h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026